IDiyas

For the Inventor, By the Inventor

Mannheim, Germany

Jens-Peter Holck

USPTO Granted Patents = 9

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 55(Granted Patents)


Company Filing History:

goldMedal9 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents

Years Active: 1987-1990

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4963686 - Certain pyridinoylamino-indolin-2-one derivatives (1990-10-16),
2. 4882342 - 5-alkylbenzimidazoles, method of use and pharmaceutical compositions (1989-11-21),
3. 4880805 - Use of alkylenediamine derivatives for the treatment of blood flow (1989-11-14),
4. 4835280 - Indoline compounds for synthesis of pharmaceutically active (1989-05-30),
5. 4810801 - Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and (1989-03-07),
6. 4780474 - Use of alkylenediamine derivatives for the treatment of blood flow (1988-10-25),
7. 4710510 - Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and (1987-12-01),
8. 4695567 - Pyrrolobenzimidazoles, pharmaceutical compositions containing them and (1987-09-22),
9. 4666923 - Pyrrolobenzimidazoles for treating heart or circulatory diseases (1987-05-19),

Title: The Innovative Contributions of Jens-Peter Holck

Introduction

Jens-Peter Holck is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of nine patents to his name, Holck's work has had a considerable impact on medical science.

Latest Patents

Holck's latest patents include innovative compounds such as certain pyridinoylamino-indolin-2-one derivatives. These compounds are characterized by a complex formula that allows for various substitutions, making them versatile in their applications. Another significant patent involves 5-alkylbenzimidazoles, which are useful for the prophylaxis or treatment of heart and circulatory diseases. These compounds aim to enhance heart contractility, lower blood pressure, and improve microcirculation.

Career Highlights

Jens-Peter Holck is currently associated with Boehringer Mannheim GmbH, a company known for its advancements in healthcare and pharmaceuticals. His work at this esteemed organization has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Throughout his career, Holck has collaborated with esteemed colleagues such as Bernd Muller-Beckmann and Klaus Strein. These collaborations have fostered a productive environment for innovation and have contributed to the success of his research endeavors.

Conclusion

Jens-Peter Holck's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…